These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1177 related articles for article (PubMed ID: 19212411)

  • 1. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
    Sreekumar A; Poisson LM; Rajendiran TM; Khan AP; Cao Q; Yu J; Laxman B; Mehra R; Lonigro RJ; Li Y; Nyati MK; Ahsan A; Kalyana-Sundaram S; Han B; Cao X; Byun J; Omenn GS; Ghosh D; Pennathur S; Alexander DC; Berger A; Shuster JR; Wei JT; Varambally S; Beecher C; Chinnaiyan AM
    Nature; 2009 Feb; 457(7231):910-4. PubMed ID: 19212411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of sarcosine metabolism in prostate cancer progression.
    Khan AP; Rajendiran TM; Ateeq B; Asangani IA; Athanikar JN; Yocum AK; Mehra R; Siddiqui J; Palapattu G; Wei JT; Michailidis G; Sreekumar A; Chinnaiyan AM
    Neoplasia; 2013 May; 15(5):491-501. PubMed ID: 23633921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.
    Heger Z; Gumulec J; Cernei N; Polanska H; Raudenska M; Masarik M; Eckschlager T; Stiborova M; Adam V; Kizek R
    Prostate; 2016 May; 76(7):679-90. PubMed ID: 26847870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcosine Up-Regulates Expression of Genes Involved in Cell Cycle Progression of Metastatic Models of Prostate Cancer.
    Heger Z; Merlos Rodrigo MA; Michalek P; Polanska H; Masarik M; Vit V; Plevova M; Pacik D; Eckschlager T; Stiborova M; Adam V
    PLoS One; 2016; 11(11):e0165830. PubMed ID: 27824899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the metabolome suggests a major potential role of sarcosine in the progression of cancer of the prostate].
    Darbon JM
    Bull Cancer; 2009 Apr; 96(4):355-6. PubMed ID: 19562840
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.
    Khan AP; Poisson LM; Bhat VB; Fermin D; Zhao R; Kalyana-Sundaram S; Michailidis G; Nesvizhskii AI; Omenn GS; Chinnaiyan AM; Sreekumar A
    Mol Cell Proteomics; 2010 Feb; 9(2):298-312. PubMed ID: 19955085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation of
    Piert M; Shao X; Raffel D; Davenport MS; Montgomery J; Kunju LP; Hockley BG; Siddiqui J; Scott PJH; Chinnaiyan AM; Rajendiran T
    J Nucl Med; 2017 Aug; 58(8):1216-1223. PubMed ID: 28302759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcosine as a potential prostate cancer biomarker--a review.
    Cernei N; Heger Z; Gumulec J; Zitka O; Masarik M; Babula P; Eckschlager T; Stiborova M; Kizek R; Adam V
    Int J Mol Sci; 2013 Jul; 14(7):13893-908. PubMed ID: 23880848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic signatures of aggressive prostate cancer.
    McDunn JE; Li Z; Adam KP; Neri BP; Wolfert RL; Milburn MV; Lotan Y; Wheeler TM
    Prostate; 2013 Oct; 73(14):1547-60. PubMed ID: 23824564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
    Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
    Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.
    Green T; Chen X; Ryan S; Asch AS; Ruiz-Echevarría MJ
    Prostate; 2013 Oct; 73(14):1561-75. PubMed ID: 23824605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
    Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
    Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
    Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
    Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics research on potential role for 9-cis-retinoic acid in breast cancer progression.
    Wu J; Yang R; Zhang L; Li Y; Liu B; Kang H; Fan Z; Tian Y; Liu S; Li T
    Cancer Sci; 2018 Jul; 109(7):2315-2326. PubMed ID: 29737597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression.
    Jentzmik F; Stephan C; Lein M; Miller K; Kamlage B; Bethan B; Kristiansen G; Jung K
    J Urol; 2011 Feb; 185(2):706-11. PubMed ID: 21168877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer--a large nested case-control study within the JANUS cohort in Norway.
    de Vogel S; Ulvik A; Meyer K; Ueland PM; Nygård O; Vollset SE; Tell GS; Gregory JF; Tretli S; Bjørge T
    Int J Cancer; 2014 Jan; 134(1):197-206. PubMed ID: 23797698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in localized prostate cancer.
    Ferro M; Buonerba C; Terracciano D; Lucarelli G; Cosimato V; Bottero D; Deliu VM; Ditonno P; Perdonà S; Autorino R; Coman I; De Placido S; Di Lorenzo G; De Cobelli O
    Future Oncol; 2016 Feb; 12(3):399-411. PubMed ID: 26768791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.
    Putluri N; Shojaie A; Vasu VT; Nalluri S; Vareed SK; Putluri V; Vivekanandan-Giri A; Byun J; Pennathur S; Sana TR; Fischer SM; Palapattu GS; Creighton CJ; Michailidis G; Sreekumar A
    PLoS One; 2011; 6(7):e21417. PubMed ID: 21789170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor activity of the transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) correlates with its ability to modulate sarcosine levels.
    Chen X; Overcash R; Green T; Hoffman D; Asch AS; Ruiz-Echevarría MJ
    J Biol Chem; 2011 May; 286(18):16091-100. PubMed ID: 21393249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.
    Cha YJ; Kim DH; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(11):7824-33. PubMed ID: 25550822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.